Company / Income Tax per Share
Vertex Pharmaceuticals Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$2.69
FY2025
5-year range
$1.49 / $3.58
FY2021-FY2025
Trend
-11.7%
vs FY2024
Sector context
#5 of 201
Health Care
What the data says
Among 201 Health Care companies, Vertex Pharmaceuticals is in the bottom 2% for income tax per share. Income Tax per Share has fluctuated over the past 10 years, ranging from $-5.87 in FY2018 to $3.58 in FY2022.
Based on SEC 10-K filings.
2.69 in FY2025 with a 5-year CAGR of +11.4%. Top quartile in the Health Care sector.
Improved from $2.96 to $2.69 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -9.1%
- 5-Year CAGR
- +11.4%
- 10-Year CAGR
- -
Sector benchmark
+99.2% above sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 11.7% year-over-year.
- Ranks #5 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2022.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.69 | -11.7% |
| FY2024 | $3.04 | +2.9% |
| FY2023 | $2.96 | -17.3% |
| FY2022 | $3.58 | +139.4% |
| FY2021 | $1.49 | -4.5% |
| FY2020 | $1.56 | +83.0% |
| FY2019 | $0.85 | +114.6% |
| FY2018 | -$5.87 | -1258.3% |
| FY2017 | -$0.43 | -738.8% |
| FY2016 | $0.07 | -46.2% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026